PIM
INBX

Platinum Investment Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Platinum Investment Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-145,966
Closed -$5.1M – 148
2024
Q1 		$5.1M Sell
145,966
-21,797
-13% -$795K 0.21% 41
2023
Q4 		$6.37M Sell
167,763
-61,273
-27% -$1.31M 0.26% 51
2023
Q3 		$4.2M Hold
229,036
– – 0.16% 54
2023
Q2 		$5.95M Buy
229,036
+6,827
+3% +$159K 0.21% 53
2023
Q1 		$4.19M Buy
222,209
+62,082
+39% +$1.44M 0.15% 62
2022
Q4 		$3.95M Buy
160,127
+13,917
+10% +$409K 0.15% 58
2022
Q3 		$2.62M Sell
146,210
-13,889
-9% -$250K 0.11% 64
2022
Q2 		$1.82M Buy
160,099
+73,170
+84% +$1.08M 0.07% 86
2022
Q1 		$1.94M Hold
86,929
– – 0.06% 86
2021
Q4 		$3.8M Sell
86,929
-16,654
-16% -$666K 0.11% 73
2021
Q3 		$3.45M Sell
103,583
-51,818
-33% -$1.58M 0.1% 80
2021
Q2 		$4.28M Hold
155,401
– – 0.1% 69
2021
Q1 		$3.12M Buy
155,401
+95,296
+159% +$2.78M 0.07% 69
2020
Q4 		$1.98M Sell
60,105
-14,895
-20% -$396K 0.05% 92
2020
Q3 		$1.35M Buy
+75,000
New +$1.36M 0.03% 96

Other funds holding INBX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Platinum Investment Management's INBX Position: Q2 2024 in Review

Platinum Investment Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 145,966 shares — an estimated $5.1M sold.

Platinum Investment Management first reported a position in INBX in Q3 2020 and held it in 15 quarters. The position peaked at $6.37M in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • Platinum Investment Management reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Platinum Investment Management sold 145,966 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $5.1M.
  • Platinum Investment Management first reported a position in Inhibrx, Inc. Common Stock in Q3 2020 and held it in 15 quarters.
  • Platinum Investment Management's Inhibrx, Inc. Common Stock position peaked at $6.37M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Platinum Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.